1,009
Views
25
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Safety and efficacy evaluation of albumin-bound paclitaxel

, , ScB, , BPharm, & , ScB

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Zeina N. Al-Mahayri, Mohammad M. AlAhmad & Bassam R. Ali. (2021) Current opinion on the pharmacogenomics of paclitaxel-induced toxicity. Expert Opinion on Drug Metabolism & Toxicology 17:7, pages 785-801.
Read now
Walter Brand, Cornelle W Noorlander, Christina Giannakou, Wim H De Jong, Myrna W Kooi, Margriet VDZ Park, Rob J Vandebriel, Irene EM Bosselaers, Joep HG Scholl & Robert E Geertsma. (2017) Nanomedicinal products: a survey on specific toxicity and side effects. International Journal of Nanomedicine 12, pages 6107-6129.
Read now
Darrell Sleep. (2015) Albumin and its application in drug delivery. Expert Opinion on Drug Delivery 12:5, pages 793-812.
Read now

Articles from other publishers (22)

Seung S. Lee, Miltiadis Paliouras & Mark A. Trifiro. (2023) Functionalized Carbon Nanoparticles as Theranostic Agents and Their Future Clinical Utility in Oncology. Bioengineering 10:1, pages 108.
Crossref
Zhichao Tian, Shuping Dong, Yang Yang, Shilei Gao, Yonghao Yang, Jinpo Yang, Peng Zhang, Xin Wang & Weitao Yao. (2022) Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study. BMC Cancer 22:1.
Crossref
Susanta Kumar Rout, Vishnu Priya, Vikas, Abhishesh Kumar Mehata & Madaswamy S. Muthu. (2022) Abciximab coated albumin nanoparticles of rutin for improved and targeted antithrombotic effect. Journal of Drug Delivery Science and Technology 76, pages 103785.
Crossref
Suna Ye, Qiqi Fang, Jinyu Yao, Jianqiang Xing, Shibo Tang & Jacey Hongjie Ma. (2021) Intravitreal Ranibizumab Had Limited Effect on Cystoid Macular Edema Due to Albumin-Bound Paclitaxel: A Case Report and Literature Review. Frontiers in Oncology 11.
Crossref
Philipp Fronik, Isabella Poetsch, Alexander Kastner, Theresa Mendrina, Sonja Hager, Katharina Hohenwallner, Hemma Schueffl, Dietmar Herndler-Brandstetter, Gunda Koellensperger, Evelyn Rampler, Joanna Kopecka, Chiara Riganti, Walter Berger, Bernhard K. Keppler, Petra Heffeter & Christian R. Kowol. (2021) Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands. Journal of Medicinal Chemistry 64:16, pages 12132-12151.
Crossref
Zhichao Tian, Fan Zhang, Po Li, Jiaqiang Wang, Jinpo Yang, Peng Zhang, Weitao Yao & Xin Wang. (2020) Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma. BMC Cancer 20:1.
Crossref
Kuldeep Rajpoot. (2020) Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications. Current Cancer Drug Targets 20:4, pages 271-287.
Crossref
Alberto A. Gabizon, Rafael T.M. de Rosales & Ninh M. La-Beck. (2020) Translational considerations in nanomedicine: The oncology perspective. Advanced Drug Delivery Reviews 158, pages 140-157.
Crossref
Sophia Ran & Lisa Volk-Draper. 2020. Tumor Microenvironment. Tumor Microenvironment 87 105 .
Dandan Wang, Yuting Wang, Guangchao Zhao, Jie Zhuang & Wei Wu. (2019) Improving systemic circulation of paclitaxel nanocrystals by surface hybridization of DSPE-PEG2000. Colloids and Surfaces B: Biointerfaces 182, pages 110337.
Crossref
Xi Guo, Hong Sun, Jihong Dong, Yi Feng, Hong Li, Rongyuan Zhuang, Peipei Wang, Weimin Cai & Yuhong Zhou. (2019) Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 139, pages 16-23.
Crossref
Rajasree Shanmuganathan, Thomas Nesakumar Jebakumar Immanuel Edison, Felix LewisOscar, Ponnuchamy Kumar, Sabarathinam Shanmugam & Arivalagan Pugazhendhi. (2019) Chitosan nanopolymers: An overview of drug delivery against cancer. International Journal of Biological Macromolecules 130, pages 727-736.
Crossref
Hong Sun, Xi Guo, Ziteng Wang, Peipei Wang, Zhe Zhang, Jihong Dong, Rongyuan Zhuang, Yuhong Zhou, Guo Ma & Weimin Cai. (2019) Alphalipoic Acid Prevents Oxidative Stress and Peripheral Neuropathy in Nab-Paclitaxel-Treated Rats through the Nrf2 Signalling Pathway. Oxidative Medicine and Cellular Longevity 2019, pages 1-11.
Crossref
Vincent Sibaud, Robert Baran, Bianca Maria Piraccini, Mario E. Lacouture & Caroline Robert. 2019. Baran & Dawber's Diseases of the Nails and their Management. Baran & Dawber's Diseases of the Nails and their Management 604 616 .
Varsha Mandloi, Veenita Yogi, OmPrakash Singh, ManishKumar Ahirwar, Suresh Yadav & HU Ghori. (2019) A comparative study of nab-paclitaxel versus cisplatin concurrent chemoradiotherapy in locally advanced cervical cancer. Clinical Cancer Investigation Journal 8:5, pages 198.
Crossref
Liang Ge, Xinru You, Jun Huang, Yuejian Chen, Li Chen, Ying Zhu, Yuan Zhang, Xiqiang Liu, Jun Wu & Qian Hai. (2018) Human Albumin Fragments Nanoparticles as PTX Carrier for Improved Anti-cancer Efficacy. Frontiers in Pharmacology 9.
Crossref
Rutian Li & Xiaoping Qian. 2017. Personalized Management of Gastric Cancer. Personalized Management of Gastric Cancer 179 188 .
XIAO-DONG JIAO, XIU LUO, WEN-XING QIN, LING-YAN YUAN & YUAN-SHENG ZANG. (2016) Paralytic ileus due to a novel anticancer drug, nab-paclitaxel: A case report. Molecular and Clinical Oncology 4:5, pages 824-826.
Crossref
Haijuan Zou, Zhongjuan Wang & Min Feng. (2015) Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery. Journal of Controlled Release 214, pages 121-133.
Crossref
Lin Chen, Feng Chen, Mengxin Zhao, Xiandi Zhu, Changhong Ke, Jiangming Yu, Zhiqiang Yan, Fulei Zhang, Yun Sun, Di Chen, Cheng Jiang, Xianxian Zhao, Yong Gao, Shangjing Guo & Wei Li. (2015) A Redox-Sensitive Micelle-Like Nanoparticle Self-Assembled from Amphiphilic Adriamycin-Human Serum Albumin Conjugates for Tumor Targeted Therapy. BioMed Research International 2015, pages 1-10.
Crossref
Nathalie Schleich, Fabienne Danhier & Véronique Préat. (2015) Iron oxide-loaded nanotheranostics: Major obstacles to in vivo studies and clinical translation. Journal of Controlled Release 198, pages 35-54.
Crossref
Samy A. F. Morad & Myles C. Cabot. 2015. Bioactive Sphingolipids in Cancer Biology and Therapy. Bioactive Sphingolipids in Cancer Biology and Therapy 211 233 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.